JP
Insider
John Patience
DirectorJohn Patience (Director) filed 2 Form 4 reports in the past 24 months (2 purchases, 0 sales), most often in AXDX. Across 1 priced purchase filing, the average 21-session return was -7.5% from execution and -3.7% from disclosure (delay-adjusted; derived). The largest single filing was $314K of AXDX (200,000 sh × $1.57, as filed), executed Dec 3 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-7.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-3.7%
same 1 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$314K
shares × price, as filed
Last traded
Dec 3 2024
Filed Dec 3 2024
Median ADV $1.8M across their filed names
50% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Open performance→Volume by month
Buys $314K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
AXDX
AXDX
AXDX · 1 buy · 0 sells
1 filing
BDSXRecent filings
AXDXPURCHASE
Accelerate Diagnostics, Inc
View filing →
$314K200,000 sh × $1.57
Exec Dec 3 2024
Filed Dec 3 2024 · 5:30 PM ET BDSXPURCHASE Biodesix, Inc. View filing → –
75,000 sh · price not plausible
Exec Nov 5 2024
Filed Nov 6 2024 · 5:30 PM ET